Polymorphisms in folate pathway and pemetrexed treatment outcome in patients with malignant pleural mesothelioma

le Goricar, Katja, Kovac, Viljem, Dolzan, Vita
Foilsithe 2014

Genetic Determinants of Parkinson's Disease: Can They Help to Stratify the Patients Based on the Underlying Molecular Defect?

le Redenšek, Sara, Trošt, Maja, Dolžan, Vita
Foilsithe in Front Aging Neurosci (2017)

Clinical-pharmacogenetic models for personalized cancer treatment: application to malignant mesothelioma

le Goričar, Katja, Kovač, Viljem, Dolžan, Vita
Foilsithe in Sci Rep (2017)

From Genomics to Omics Landscapes of Parkinson's Disease: Revealing the Molecular Mechanisms

le Redenšek, Sara, Dolžan, Vita, Kunej, Tanja
Foilsithe in OMICS (2018)

Genetic variability in sodium-glucose cotransporter 2 influences glycemic control and risk for diabetic retinopathy in type 2 diabetes patients

le Klen, Jasna, Goričar, Katja, Dolžan, Vita
Foilsithe in J Med Biochem (2020)

Genetic Variability in Molecular Pathways Implicated in Alzheimer's Disease: A Comprehensive Review

le Vogrinc, David, Goričar, Katja, Dolžan, Vita
Foilsithe in Front Aging Neurosci (2021)

Extracellular Vesicles: A Novel Tool Facilitating Personalized Medicine and Pharmacogenomics in Oncology

le Goričar, Katja, Dolžan, Vita, Lenassi, Metka
Foilsithe in Front Pharmacol (2021)

Genetic polymorphisms in homologous recombination repair genes in healthy Slovenian population and their influence on DNA damage

le Goricar, Katja, Erculj, Nina, Zadel, Maja, Dolzan, Vita
Foilsithe 2012

The Role of Genetic Factors and Kidney and Liver Function in Glycemic Control in Type 2 Diabetes Patients on Long-Term Metformin and Sulphonylurea Cotreatment

le Klen, Jasna, Goričar, Katja, Janež, Andrej, Dolžan, Vita
Foilsithe 2014

NLRP3 Inflammasome Polymorphism and Macrovascular Complications in Type 2 Diabetes Patients

le Klen, Jasna, Goričar, Katja, Janež, Andrej, Dolžan, Vita
Foilsithe in J Diabetes Res (2015)

NLRP3 and CARD8 Polymorphisms Influence Higher Disease Activity in Rheumatoid Arthritis

le Jenko, Barbara, Praprotnik, Sonja, Tomšic, Matija, Dolžan, Vita
Foilsithe in J Med Biochem (2016)

Matrix Metalloproteinases Polymorphisms as Prognostic Biomarkers in Malignant Pleural Mesothelioma

le Štrbac, Danijela, Goričar, Katja, Dolžan, Vita, Kovač, Viljem
Foilsithe in Dis Markers (2017)

Matrix Metalloproteinases Polymorphisms as Baseline Risk Predictors in Malignant Pleural Mesothelioma

le Strbac, Danijela, Goricar, Katja, Dolzan, Vita, Kovac, Viljem
Foilsithe in Radiol Oncol (2018)

Evaluation of Matrix Metalloproteinase 9 Serum Concentration as a Biomarker in Malignant Mesothelioma

le Štrbac, Danijela, Goričar, Katja, Dolžan, Vita, Kovač, Viljem
Foilsithe in Dis Markers (2019)

Manganese and Extracellular Superoxide Dismutase Polymorphisms and Risk for Asbestosis

le Franko, Alenka, Dodič-Fikfak, Metoda, Arnerić, Niko, Dolžan, Vita
Foilsithe 2009

Inducible Nitric Oxide Synthase Genetic Polymorphism and Risk of Asbestosis

le Franko, Alenka, Dodič-Fikfak, Metoda, Arnerić, Niko, Dolžan, Vita
Foilsithe 2011

Influence of 5-HT1A and 5-HTTLPR genetic variants on the schizophrenia symptoms and occurrence of treatment-resistant schizophrenia

le Terzić, Tea, Kastelic, Matej, Dolžan, Vita, Plesničar, Blanka Kores
Foilsithe in Neuropsychiatr Dis Treat (2015)

Clinical-Pharmacogenetic Predictive Models for Time to Occurrence of Levodopa Related Motor Complications in Parkinson’s Disease

le Redenšek, Sara, Jenko Bizjan, Barbara, Trošt, Maja, Dolžan, Vita
Foilsithe in Front Genet (2019)

Telomere Attrition in Neurodegenerative Disorders

le Levstek, Tina, Kozjek, Eva, Dolžan, Vita, Trebušak Podkrajšek, Katarina
Foilsithe in Front Cell Neurosci (2020)

Clinical and Clinical-Pharmacogenetic Models for Prediction of the Most Common Psychiatric Complications Due to Dopaminergic Treatment in Parkinson’s Disease

le Redenšek, Sara, Jenko Bizjan, Barbara, Trošt, Maja, Dolžan, Vita
Foilsithe in Int J Neuropsychopharmacol (2020)